1. 185 A Review of the Systemic Medical Complications Following Joint Replacement. (19th August 2022) Authors: Curlewis, K; Leung, B; Thornhill, C; Sinclair, L; Chan, G; Ricketts, D Journal: British journal of surgery Issue: Volume 109(2022)Supplement 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 28 Humoral response to SARS-CoV-2 vaccination among heart transplant recipients aged 18–70 years of age administered two doses of an adenoviral vector (ChAdOx1 nCoV-19) vaccine and a messenger RNA (BNT162b2) booster. (6th October 2022) Authors: Tanner, R; Perez-Garcia, C; Chan, G; Dempsey, E; Heffernan, E; O'Neill, J; Lynch, B; Hannan, M; Joyce, E Journal: Heart Issue: Volume 108(2022)Supplement 3 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 35 Medical Complications After Total Ankle Arthroplasty: A Review of the Evidence. (19th August 2022) Authors: Curlewis, K; Leung, B; Sinclair, L; Chan, G; Bendall, S; Ricketts, D Journal: British journal of surgery Issue: Volume 109(2022)Supplement 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 470 Financial and Efficacy Analysis of a Centralised Neck of Femur Fracture Service. (12th October 2021) Authors: Ngo, V; Chan, G; Edmondson, M Journal: British journal of surgery Issue: Volume 108:Supplement 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A199 EFFICACY OF TOFACITINIB RETREATMENT FOR ULCERATIVE COLITIS AFTER TREATMENT INTERRUPTION: RESULTS FROM THE OCTAVE CLINICAL TRIALS. (1st March 2018) Authors: Panés, J; Bressler, B; Colombel, J F; Lawendy, N; Maller, E; Zhang, H; Woodworth, D; Chan, G; Su, C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 1(2018)Supplement 2 Page Start: 294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS. (15th March 2019) Authors: Sandborn, W J; Panés, J; Panaccione, R; D'Haens, G; Sands, B E; Su, C; Moscariello, M; Jones, T V; Pedersen, R D; Friedman, G S; Lawendy, N; Chan, G Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ADALIMUMAB IN THE MAINTENANCE OF REMISSION FOR INFLAMMATORY BOWEL DISEASE: NEED FOR WEIGHT-BASED DOSING?. (8th June 2013) Authors: Chan, G; Martin, H; Farrell, R Journal: Gut Issue: Volume 62(2013)Supplement 2 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP023 Tofacitinib for the treatment of ulcerative colitis: up to 4.4 years of safety data from global clinical trials. (16th January 2018) Authors: Sandborn, W J; Panés, J; D'Haens, G R; Sands, B E; Su, C; Moscariello, M; Jones, T V; Pedersen, R D; Friedman, G S; Lawendy, N; Chan, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DOP026 Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open. (16th January 2018) Authors: Sands, B E; Moss, A C; Armuzzi, A; Marshall, J K; Lindsay, J O; Sandborn, W J; Danese, S; Tsilkos, K; Lawendy, N; Zhang, H; Friedman, G S; Chan, G; Krichbaum, D W; Su, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. DOP027 Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Results of the OCTAVE open study for tofacitinib 8-week induction non-responders. (16th January 2018) Authors: Feagan, B G; Dubinsky, M C; Lukas, M; Quirk, D; Nduaka, C I; Maller, E; Lawendy, N; Kayhan, C; Wang, W; Chan, G; Su, C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗